C

Cityblock Health

Delivers Medicaid-focused compassionate healthcare services

Registered Nurse – LTSS Case Management Liaison

Full-Time
$100k - $105k+ Equity program
Mid
Bachelor's
Massachusetts, USA
HybridMust live in Massachusetts; approximately 25% in-person for meetings, training, and backup support, with arrangements subject to change.
Medical, Clinical & Veterinary

About the job

Requirements
  • Hold an active, unrestricted Registered Nurse or Nurse Practitioner license in good standing in Massachusetts.
  • Graduate from an accredited school of nursing.
  • Have at least 3 years of clinical experience.
  • Have working familiarity with long term services and supports, including home and community-based services, personal care services, adult day health, home health, and durable medical equipment.
  • Understand MassHealth LTSS coverage criteria and Medicaid and Medicare Advantage authorization, appeal, and grievance processes, including Board of Hearings procedure and continuation of services during appeal.
  • Have experience serving dually eligible, medically complex, or behavioral health-involved populations.
  • Synthesize incomplete and conflicting documentation into a defensible functional picture, identify when the record is insufficient, and determine what information is needed to close the gap.
  • Produce clear, criteria-anchored clinical narratives that can withstand external review without supplementation.
  • Manage competing deadlines independently and maintain accurate status visibility on every open case.
  • Conduct professional clinical conversations with health plan Utilization Management nurses and medical directors, including when there is disagreement.
  • Apply Motivational Interviewing and Trauma-Informed Care principles when engaging members on service adjustments and appeal decisions.
  • Be proficient in electronic health record and care facilitation platforms, including Commons and Athena, and telephony tooling such as TalkDesk; document accurately and contemporaneously across systems that do not integrate cleanly.
  • Resolve day-to-day review and coordination issues using policy and established processes, and escalate issues when appropriate.
  • Adapt to changes in plan requirements, regulation, criteria sets, and internal workflows.
Responsibilities
  • Synthesize internal assessments, including MDS-HC and comprehensive member assessments where applicable, recent visit notes, medication reconciliation records, and external care and agency documentation to evaluate members’ clinical and functional status against established level-of-care criteria.
  • Identify documentation gaps that could weaken a determination and work with the assigned care team to close them before submission.
  • Apply criteria specified by the applicable contract and state LTSS regulation to produce clinical determinations and written rationales for initial requests and annual redeterminations, including recommendations to continue, adjust, or discontinue services.
  • Submit clinical determinations and supporting documentation to health plan Utilization Management teams and manage ongoing clinical exchange through resolution, including responses to requests for additional information and clinician-to-clinician discussions where required.
  • Serve as the standing clinical point of contact for plan partners on LTSS review matters.
  • Manage a dedicated appeal queue end to end; confirm appeal justifications have been reviewed directly with members and that their stated goals and preferences are reflected in the packets.
  • Assemble structured appeal submissions, track filing deadlines and continuation-of-services timelines, and prepare clinical summary materials for Board of Hearings proceedings.
  • Escalate cases carrying adverse-precedent risk to clinical leadership and Compliance.
  • Independently manage a daily queue of initial reviews, annual redeterminations, and ad hoc appeal requests against turnaround standards set by plan contracts and applicable regulations.
  • Prioritize queue work by deadline exposure and member access risk, and flag volume or capacity constraints before turnaround standards are missed.
  • Serve as the clinical bridge between market care teams, external LTSS service agencies, and health plan clinical staff.
  • Use the RN Triage Needed workflow to route members requiring clinical escalation to the market team, and communicate changes in authorized service levels to the assigned care team for incorporation into the care plan and follow-up.
  • Translate clinical determinations and their operational implications for non-clinical staff, members, and families.
  • Document reviews, plan communications, and appeal activity in Commons and Athena in accordance with Cityblock standards and audit requirements, including accurate ICD and CPT documentation supporting clinical findings.
  • Maintain consistency of criteria application across reviewers, participate in inter-rater reliability review, and raise recurring adverse decision patterns, criteria interpretation conflicts, and workflow friction with clinical and operational leadership.
  • Adapt to changes in plan requirements, state regulation, criteria sets, and internal tooling, and help translate those changes into workable practices for market teams.
  • Solicit and relay frontline feedback when LTSS review processes create friction for staff or members.
  • Escalate cases in which clinical criteria and financial interests appear to diverge to clinical leadership and Compliance.
Desired Qualifications
  • Direct experience in utilization management, clinical review, or medical necessity determination.
  • Additional state licensure or multistate compact privileges.
  • Experience with functional assessment instruments such as MDS-HC, MDS, or a state equivalent.
  • Proficiency in multiple languages.

About the company

Cityblock Health provides integrated medical, mental health, and social services for underserved communities, with a focus on Medicaid and lower-income Medicare plans. It coordinates care through a dedicated team of doctors, nurses, social workers, and mental health advocates who tailor support to each member’s needs. Services include in-person clinics, virtual care, and mobile urgent care for non-life-threatening emergencies. Unlike traditional providers, Cityblock combines healthcare with social support (housing, food security, childcare, addiction help) to address root health factors. Financial assistance helps cover copays, often making care free at the point of use. The company’s goal is to improve health outcomes for marginalized populations by offering accessible, compassionate, and proactive care that reduces unnecessary ER visits and connects patients with comprehensive resources.

Company Size

501-1,000

Company Stage

Series E

Total Funding

$1.1B

Headquarters

New York City, New York

Founded

2017

Get referred to Cityblock Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • General Catalyst led Cityblock’s $116 million Series E on August 20, 2026.
  • Cityblock reported $2.2 billion annualized revenue and nearly 200,000 members in August 2026.
  • Homeward adds 50 counties and roughly 50,000 rural patients, widening payer reach.

What critics are saying

  • Medicaid cuts and tighter Medicare Advantage rates squeeze margins immediately after August 2026.
  • Homeward integration threatens execution across technology, data, and operations before 2027 renewals.
  • If reimbursement compression outpaces growth, Cityblock’s capital-heavy model collapses under a 2027 cash crunch.

What makes Cityblock Health unique

  • Cityblock’s August 2026 platform spans urban Medicaid and rural Medicare Advantage through Homeward.
  • Its CORE operating system turns social, behavioral, and clinical data into care actions.
  • Humana’s July 1, 2026 North Carolina contract validates 24/7 wraparound service delivery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Comprehensive health, dental, & vision coverage
  • 12 weeks parental leave
  • 401(k)
  • 20 days vacation
  • Company retreats & events

Growth & Insights and Company News

6 month growth

-3%

1 year growth

-1%

2 year growth

0%
Tracxn
Oct 10th, 2026
Cityblock - Funding & investors.

Cityblock - Funding & investors. Last updated: October 10, 2026 Cityblock's funding rounds. Cityblock has raised a total of $1.02B over 7 funding rounds: 3 Early-Stage and 4 Late-Stage round s. Cityblock's largest funding round so far was a Series D round for $400M in Sep 2021. Here is the list of all funding rounds of Cityblock: | Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors | | Aug 20, 2026 | $116M | Series E | - | - | General Catalyst | - | | Sep 03, 2021 | $400M | Series D | $5.7B | - | SoftBank Group | - | | Mar 15, 2021 | $192M | Series C | $5.7B | - | Tiger Global Management | General Catalyst, Maverick Ventures, Thrive Capital, Redpoint Ventures, Wellington, Kinnevik, Echo Health Ventures, 8VC | | Dec 09, 2020 | $160M | Series C | $1B | - | General Catalyst | Wellington, Kinnevik, Maverick Ventures, Thrive Capital, 8VC, Echo Health Ventures, Redpoint Ventures, EmblemHealth, Goldman Sachs | | Jun 17, 2020 | $53.5M | Series B | $1B | - | Kinnevik | Alphabet, Goldman Sachs | | Mar 29, 2019 | $65.1M | Series B | $470M | - | Redpoint Ventures | 8VC, Echo Health Ventures, StartUp Health, Maverick Ventures, Sidewalk Labs, Thrive Capital, EmblemHealth, Town Hall Ventures | | Dec 20, 2017 | $20.8M | Series A | - | - | Maverick Ventures | Thrive Capital, Sidewalk Labs, Oxeon Partners | Cityblock's investors. Cityblock has total 28 investor s, 28 are institutional investors including General Catalyst and 27 others. Here is the list of institutional investors of Cityblock: * General Catalyst, located in Cambridge (United States), made their first investment in Cityblock on Dec 09, 2020 in its Series C round. * SoftBank Group, located in Minato City (Japan), made their first investment in Cityblock on Sep 03, 2021 in its Series D round. * Tiger Global Management, located in New York City (United States), made their first investment in Cityblock on Mar 15, 2021 in its Series C round. * Maverick Ventures, located in San Francisco (United States), made their first investment in Cityblock on Dec 20, 2017 in its Series A round. * Thrive Capital, located in New York City (United States), made their first investment in Cityblock on Dec 20, 2017 in its Series A round. * Redpoint Ventures, located in Woodside (United States), made their first investment in Cityblock on Mar 29, 2019 in its Series B round. * Wellington, located in Boston (United States), made their first investment in Cityblock on Dec 09, 2020 in its Series C round. * Kinnevik, located in Stockholm (Sweden), made their first investment in Cityblock on Jun 17, 2020 in its Series B round. * Echo Health Ventures, located in Seattle (United States), made their first investment in Cityblock on Mar 29, 2019 in its Series B round. * 8VC, located in Austin (United States), made their first investment in Cityblock on Mar 29, 2019 in its Series B round. * EmblemHealth, located in New York City (United States), made their first investment in Cityblock on Mar 29, 2019 in its Series B round. * Goldman Sachs, located in New York City (United States), made their first investment in Cityblock on Jun 17, 2020 in its Series B round. * Alphabet, located in Mountain View (United States), made their first investment in Cityblock on Jun 17, 2020 in its Series B round. * StartUp Health, located in San Francisco (United States), made their first investment in Cityblock on Mar 29, 2019 in its Series B round. * Sidewalk Labs, located in New York City (United States), made their first investment in Cityblock on Dec 20, 2017 in its Series A round. * Town Hall Ventures, located in Minneapolis (United States), made their first investment in Cityblock on Mar 29, 2019 in its Series B round. * Oxeon Partners, located in New York City (United States), made their first investment in Cityblock on Dec 20, 2017 in its Series A round. Are you a Founder? FAQs about Cityblock's funding and investors. Explore latest companies that raised funding recently * Exein - raised a funding of $270M in Series D round held on Sep 15, 2026. * Exein - raised a funding in Conventional Debt round held on Sep 15, 2026. * Magnitude Biosciences - raised a funding of $1.73M in Series A round held on Sep 15, 2026. * OriginalVoices - raised a funding of $1.35M in Seed round held on Sep 15, 2026. * Magnitude Biosciences - raised a funding of $292K in Grant (prize money) round held on Sep 15, 2026.

DistilInfo
Sep 2nd, 2026
Health tech funding surges across August.

Health tech funding surges across August. Health tech funding remained active in August 2026 as four companies collectively announced $291 million in financing across value-based care, AI-powered home diagnostics, musculoskeletal technology and biotechnology. Cityblock Health led the group with a $116 million Series E, followed by Happy Health with $75 million and separate $50 million rounds for Flagler Health and Network Bio. The investments demonstrate how healthcare capital is increasingly concentrating around companies that combine artificial intelligence with scalable care delivery, clinical data or operational infrastructure. The broader market has already shown strong momentum this year. Rock Health reported that U.S. digital health startups raised $4 billion across 110 deals during the first quarter of 2026, with 59% of the capital concentrated in just 12 mega-deals. The firm also noted that AI has become so common across digital health businesses that it is increasingly viewed as an operating requirement rather than a separate investment category. Health tech funding supports Cityblock expansion. Cityblock Health announced the largest of the four rounds, raising $116 million in Series E financing led by General Catalyst. The company provides medical, behavioral and social care through home visits, virtual services and community clinics, with a major focus on Medicaid, Medicare and dual-eligible populations. The funding accompanied Cityblock's agreement to acquire Homeward Health, which specializes in rural healthcare. Cityblock plans to invest in the combined organization's technology, data infrastructure, care model and operations. Health tech funding expands value-based care. The acquisition gives Cityblock an opportunity to extend its care model into rural communities and additional Medicare Advantage populations. Cityblock says it now serves almost 200,000 members and has reached approximately $2.2 billion in annualized revenue, up 77% year over year. The investment illustrates why capital continues flowing toward platforms that can combine clinical services with technology rather than relying exclusively on software. Investors increasingly want evidence that healthcare technology can improve outcomes while supporting financially sustainable care delivery. Happy Health raises $75 million. Happy Health secured $75 million in Series A funding from ARCH Venture Partners and OpenLoop to expand its AI-powered home healthcare platform. The company's first major application focuses on sleep apnea. Happy Health uses an FDA-cleared smart ring to collect physiological information that can support at-home diagnosis, treatment management and ongoing monitoring. The company wants to move beyond occasional healthcare measurements toward continuous monitoring. Its platform establishes personalized health baselines and uses AI to identify meaningful changes that clinicians may need to review. Health tech funding moves care home. Happy Health's financing reflects growing investor interest in moving more diagnosis and monitoring away from hospitals and clinics. Home-based technologies can potentially make healthcare more convenient while producing longitudinal information that one-time medical visits cannot provide. Sleep is the company's initial focus, but Happy Health intends to build infrastructure that can eventually support additional chronic conditions. The challenge will be demonstrating that continuous monitoring improves clinical decisions rather than simply producing more data. Flagler Health secures $50 million. Flagler Health raised $50 million in Series B funding to expand its AI-native operating system for musculoskeletal care. Bessemer Venture Partners led the round, with participation from SignalFire, Alumni Ventures, Streamlined, 186 Ventures, Proof VC, Tribeca Venture Partners and Offscript. The financing brings Flagler's total capital raised to approximately $63 million. The company supports musculoskeletal practices with technology designed to improve operations and manage patients between appointments. Healthcare AI targets practice operations. Musculoskeletal care is a large market involving orthopedic practices, rehabilitation, physical therapy and other specialties. Flagler's strategy reflects another emerging healthcare investment theme: AI does not necessarily need to make diagnoses to generate value. Technology that improves scheduling, patient engagement, practice administration and between-visit care can create measurable operational returns while reducing repetitive work for healthcare teams. The new capital will support Flagler's nationwide expansion. Network Bio launches with $50 million. Network Bio also entered the market with $50 million in financing from investors including Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund and JSL Health Capital. The Palo Alto biotechnology company is building disease-specific AI models using large-scale human biological data. Its datasets combine tissue, blood, molecular information and longitudinal clinical outcomes from academic biobanks. The company plans to use its technology across diagnostics, biomarker discovery and drug development. Health tech funding targets biological data. Network Bio represents a different form of healthcare AI investment. Instead of focusing primarily on administrative workflows or care delivery, the company is applying artificial intelligence directly to human biological datasets. Its research network includes academic medical centers and is designed to create standardized datasets that AI models can use to identify disease signals. This model highlights the growing strategic value of proprietary, clinically meaningful data as foundation models become increasingly available. Health tech funding rewards scalable platforms. The four August deals cover very different healthcare markets, but several common themes connect them. Each company combines technology with a difficult healthcare problem: Cityblock with complex and rural populations, Happy Health with continuous home monitoring, Flagler with MSK operations and Network Bio with biomedical discovery. AI is present across all four models, but investors appear to be funding more than algorithms. They are backing organizations with care infrastructure, clinical data, provider networks or specialized workflows that may be difficult for competitors to reproduce. That trend aligns with Rock Health's assessment that AI has become increasingly standard across digital health rather than a standalone differentiator. The August rounds therefore suggest that health tech funding is moving toward companies that can demonstrate how AI connects to real healthcare delivery, proprietary data and scalable business models. As capital remains selective, startups will increasingly need to prove not simply that their technology works, but that it solves a meaningful healthcare problem and can support sustainable growth.

FinSMEs
Aug 24th, 2026
Cityblock Health raises $116M Series E, acquires Homeward to reach $2.2B revenue

Cityblock Health, a New York-based technology-driven healthcare provider platform, has raised $116 million in Series E funding led by General Catalyst. The company also announced a definitive agreement to acquire Homeward Health, a rural-first Medicare Advantage care provider, in an all-stock transaction. These combined milestones elevate Cityblock's annualized revenue to $2.2 billion, serving nearly 200,000 active members across urban and rural environments. The company will use the capital to scale its integrated provider capabilities across Medicare Advantage, Medicaid, and dual-eligible patient populations, expand its technical engineering teams, and build out its AI-driven clinical operations software. Led by co-founder and CEO Dr Toyin Ajayi, Cityblock develops an AI-native outcomes-based care delivery platform leveraging its proprietary operating system, CORE, to apply predictive analytics for identifying individual care deficits.

RamaOnHealthcare
Aug 23rd, 2026
Cityblock to acquire Homeward Health, secures $116M Series E.

Cityblock to acquire Homeward Health, secures $116M Series E. MedCity News August 23, 2026 Marissa Plescia Cityblock Health plans to acquire rural healthcare provider Homeward Health and has raised $116 million to expand its value-based care model to rural and Medicare Advantage populations. Cityblock, a value-based provider, plans to acquire rural healthcare provider Homeward Health in an all-stock transaction and has raised $116 million in Series E funding, it announced on Thursday. New York City-based Cityblock offers clinical care, behavioral health care and social care in patients' homes, virtually and in community-based clinics. It primarily serves Medicaid and dual-eligible populations. The company's AI-powered operating system aggregates physical, behavioral and social health data to provide care teams with predictive insights into members. Homeward, meanwhile, is a value-based care company supporting rural patients through in-home and virtual visits...

MedCity News
Aug 23rd, 2026
Cityblock to acquire Homeward Health, secures $116M Series E.

Cityblock to acquire Homeward Health, secures $116M Series E. Cityblock Health plans to acquire rural healthcare provider Homeward Health and has raised $116 million to expand its value-based care model to rural and Medicare Advantage populations. Cityblock, a value-based provider, plans to acquire rural healthcare provider Homeward Health in an all-stock transaction and has raised $116 million in Series E funding, it announced on Thursday. New York City-based Cityblock offers clinical care, behavioral health care and social care in patients' homes, virtually and in community-based clinics. It primarily serves Medicaid and dual-eligible populations. The company's AI-powered operating system aggregates physical, behavioral and social health data to provide care teams with predictive insights into members. Homeward, meanwhile, is a value-based care company supporting rural patients through in-home and virtual visits. It connects patients to transportation services, nutritional and lifestyle support, home and community assistance and chronic condition assistance. The company serves nearly 50,000 members and has relationships with payers including Blue Cross Blue Shield of Michigan and Priority Health. presented by What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes. "Cityblock and Homeward are mission-aligned organizations serving complex, complementary populations... For us, Homeward adds a major growth vector in Medicare Advantage and, for the first time, the operating model to go rural at scale," Mike Roaldi, Cityblock's president, told MedCity News. Homeward will maintain its current brand to ensure continuity for members and the company's CEO, Dr. Jenny Schneider, will remain connected with Cityblock as a "trusted advisor," Roaldi added. The acquisition is supported by Cityblock's $116 million Series E round, which was led by General Catalyst. This funding will be used to invest in the combined platform, including optimizing operations, the care model, technology and data infrastructure, according to Roaldi. The announcement comes amid Medicaid cuts and tightening Medicare Advantage reimbursement rates, affecting both Cityblock and Homeward members. presented by By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients. "We think the answer to funding pressures in government programs isn't to retreat from them - it's to get radically better and more efficient at delivering outcomes for the people who depend on taxpayer-funded healthcare," said Toyin Ajayi, CEO and co-founder of Cityblock Health, in a blog post. "That's exactly why we're going to serve more Medicare Advantage members alongside continuing to serve individuals who are dual-eligible and those who receive Medicaid. We believe the same AI-native, outcomes-first model that has enabled us to win in Medicaid is exactly what rural Medicare Advantage and dual-eligible populations need too." Roaldi added that the acquisition of Homeward brings Cityblock one step closer to building a national operating system for government-funded healthcare at scale. "Cityblock brings a decade of care model and data infrastructure; Homeward brings proven rural reach. Together, we can serve complex populations regardless of geography - and we'll keep investing in the technology and care model that make that possible, whether through acquisition, partnership, or organic growth," Roaldi said.